Global Pizotifen Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pizotifen Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Pizotifen (INN) or pizotyline (USAN), trade name Sandomigran, is a benzocycloheptene-based drug used as a medicine, primarily as a preventive to reduce the frequency of recurrent migraine headaches
Pizotifen report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pizotifen market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Antimigraine Agent and Serotonin Receptor Antagonist are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pizotifen industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pizotifen key manufacturers include Ibn Sina Pharmaceutical, Duopharma Biotech, Aristopharma, Novartis, AFT Pharmaceuticals, Teva Pharmaceuticals, Sine Pharmaceutical, Laema Chemi Pharma and Kalbe, etc. Ibn Sina Pharmaceutical, Duopharma Biotech, Aristopharma are top 3 players and held % sales share in total in 2022.
Pizotifen can be divided into Hospital and Drug Store, etc. Hospital is the mainstream product in the market, accounting for % sales share globally in 2022.
Pizotifen is widely used in various fields, such as Antimigraine Agent and Serotonin Receptor Antagonist, etc. Antimigraine Agent provides greatest supports to the Pizotifen industry development. In 2022, global % sales of Pizotifen went into Antimigraine Agent filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pizotifen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Ibn Sina Pharmaceutical
Duopharma Biotech
Aristopharma
Novartis
AFT Pharmaceuticals
Teva Pharmaceuticals
Sine Pharmaceutical
Laema Chemi Pharma
Kalbe
Segment by Type
Hospital
Drug Store
Antimigraine Agent
Serotonin Receptor Antagonist
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pizotifen market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pizotifen, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pizotifen industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pizotifen in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pizotifen introduction, etc. Pizotifen Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pizotifen market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Pizotifen report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pizotifen market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Antimigraine Agent and Serotonin Receptor Antagonist are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pizotifen industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pizotifen key manufacturers include Ibn Sina Pharmaceutical, Duopharma Biotech, Aristopharma, Novartis, AFT Pharmaceuticals, Teva Pharmaceuticals, Sine Pharmaceutical, Laema Chemi Pharma and Kalbe, etc. Ibn Sina Pharmaceutical, Duopharma Biotech, Aristopharma are top 3 players and held % sales share in total in 2022.
Pizotifen can be divided into Hospital and Drug Store, etc. Hospital is the mainstream product in the market, accounting for % sales share globally in 2022.
Pizotifen is widely used in various fields, such as Antimigraine Agent and Serotonin Receptor Antagonist, etc. Antimigraine Agent provides greatest supports to the Pizotifen industry development. In 2022, global % sales of Pizotifen went into Antimigraine Agent filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pizotifen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Ibn Sina Pharmaceutical
Duopharma Biotech
Aristopharma
Novartis
AFT Pharmaceuticals
Teva Pharmaceuticals
Sine Pharmaceutical
Laema Chemi Pharma
Kalbe
Segment by Type
Hospital
Drug Store
Segment by Application
Antimigraine Agent
Serotonin Receptor Antagonist
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pizotifen market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pizotifen, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pizotifen industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pizotifen in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pizotifen introduction, etc. Pizotifen Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pizotifen market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
